Literature DB >> 29354652

Effect of Centruroides antivenom on reversal of methamphetamine-induced hyperkinesis and hyperthermia in rats.

Pouran Malekzadeh1, Jackie Hu2,3, Alexander J Sandweiss2, Nina Ameli1, Philippe Bierny1, Tally M Largent-Milnes2, Todd W Vanderah2, Farshad Shirazi3,4.   

Abstract

CONTEXT: Methamphetamine (MA) toxicity is a major health concern causing agitation, hyperkinesia, hyperthermia, and even death, affecting 24.7 million people worldwide. It has been observed that MA generates movement disorders in children similar to that of scorpion envenomation. Four cases have been reported where MA intoxication in children were both subjectively and objectively improved as indicated by the reversal of nystagmus and movement disorders following administration of Centruroides antivenom (AV) therapy.
OBJECTIVE: Here, we aimed to demonstrate the reversal of MA induced movement disorders and hyperthermia by scorpion AV equine immune F(ab')2 in rats.
MATERIALS AND METHODS: Baseline core temperature and locomotor activity in adult male Sprague-Dawley rats (200-220 g) were evaluated prior to acute administration of AV (20 mg/kg, intraperitoneally, i.p.) + MA (10 mg/kg, i.p.) or control. Core body temperature was reassessed 10, 50, and 80 min post injection while locomotor activity was reassessed 20-35 and 60-75 min post injection.
RESULTS: At 20-35 min, Saline + MA and BSA + MA groups showed a significant increase in the number of fine events compared to their respective control groups Saline + Saline and BSA + Saline, which indicates an increase in paw movements of animals in situ (p = 0.008, p = 0.006, respectively). In contrast, AV + MA demonstrated a non-significant increase in fine activity compared to the control group AV + Saline). At 60-75 min, the AV + MA treatment group were less likely to engage in locomotor activity indicated by the significant decrease in exploratory events compared to BSA + MA control group (p = 0.041). No significant percent change in core body temperature was observed in the AV + MA treatment group compared to the control groups, AV + Saline and BSA + MA. DISCUSSION: Here, we provide evidence for some aspects of MA-induced hyperkinesia but not hyperthermia reversed by scorpion AV. Further preclinical studies involving adolescent rodents may be necessary to completely mimic the reversal of MA toxicity seen in children in the clinic.

Entities:  

Keywords:  Antivenom; antivenins; mechanism; methamphetamine; rats; symptomatology

Year:  2017        PMID: 29354652      PMCID: PMC5771266          DOI: 10.13188/2327-204X.1000020

Source DB:  PubMed          Journal:  J Pharm Pharmacol (Los Angel)


  15 in total

1.  Electrical resistance across the blood-brain barrier in anaesthetized rats: a developmental study.

Authors:  A M Butt; H C Jones; N J Abbott
Journal:  J Physiol       Date:  1990-10       Impact factor: 5.182

2.  2004 Annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System.

Authors:  William A Watson; Toby L Litovitz; George C Rodgers; Wendy Klein-Schwartz; Nicole Reid; Jessica Youniss; Anne Flanagan; Kathleen M Wruk
Journal:  Am J Emerg Med       Date:  2005-09       Impact factor: 2.469

3.  Infant methamphetamine toxicity posing as scorpion envenomation.

Authors:  A R Nagorka; P S Bergeson
Journal:  Pediatr Emerg Care       Date:  1998-10       Impact factor: 1.454

4.  Inadvertent methamphetamine poisoning in pediatric patients.

Authors:  P Kolecki
Journal:  Pediatr Emerg Care       Date:  1998-12       Impact factor: 1.454

Review 5.  Development of active and passive human vaccines to treat methamphetamine addiction.

Authors:  W Brooks Gentry; Daniela Rüedi-Bettschen; S Michael Owens
Journal:  Hum Vaccin       Date:  2009-04-20

6.  Anti-N-methyl-D-aspartate receptor (anti-NMDAR) encephalitis: an etiology worth considering in the differential diagnosis of delirium.

Authors:  M Punja; A C Pomerleau; J J Devlin; B W Morgan; J G Schier; M D Schwartz
Journal:  Clin Toxicol (Phila)       Date:  2013-08-20       Impact factor: 4.467

7.  Methamphetamine disrupts blood-brain barrier function by induction of oxidative stress in brain endothelial cells.

Authors:  Servio H Ramirez; Raghava Potula; Shongshan Fan; Tess Eidem; Anil Papugani; Nancy Reichenbach; Holly Dykstra; Babette B Weksler; Ignacio A Romero; Pierre O Couraud; Yuri Persidsky
Journal:  J Cereb Blood Flow Metab       Date:  2009-08-05       Impact factor: 6.200

8.  Methamphetamine-induced behavioural effects and brain concentrations of methamphetamine and its metabolite amphetamine in mice.

Authors:  J F Brien; J C Kitney; J E Peachey; B J Rogers
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1978-11

Review 9.  Pharmacologic mechanisms of crystal meth.

Authors:  Stephen J Kish
Journal:  CMAJ       Date:  2008-06-17       Impact factor: 8.262

10.  Methamphetamine Ingestion Misdiagnosed as Centruroides sculpturatus Envenomation.

Authors:  Joshua Strommen; Farshad Shirazi
Journal:  Case Rep Emerg Med       Date:  2015-01-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.